Retrovirus-Mediated Gene Transfer

Transgenic Animal Technology: A Laboratory Handbook: Second Edition

Volumn , Issue , 2002, Pages 173-193

  Kim, Teoan ^a  

^a Catholic University of Daegu   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84941107658     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-057480-6.50010-1     Document Type: Chapter

References (70)

1. Adam M.A., Miller A.D. Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions. J. Virol. 1988, 62:3802-3806.
2. Adam M.A., Ramesh N., Miller A.D., Osborne W.R.A. Internal initiation of translation in retroviral vectors carrying picornavirus 5' nontranslated regions. J. Virol. 1991, 65:4985-4990.
3. Albritton L.M., Tseng L., Scadden D., Cunningham J.M. A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell (Cambridge, MA) 1989, 57:659-666.
4. Andreadis S.T., Brott D., Fuller A.O., Palsson B.O. Moloney murine leukemia virus-derived retroviral vector decay intracellularly with a half-life in the range of 5.5 to 7.7 hours. J. Virol. 1997, 71:7541-7548.
5. Aran J.M., Gottesman M.M., Pastan I. Construction and characterization of bicistronic retroviral vectors encoding the multidrug transporter and beta galactosidase or green fluorescent protein. Cancer Gene Ther. 1998, 5:195-206.
6. Artelt P., Grannemann R., Stocking C., Friel J., Bartsch J., Hauser H. The prokaryotic neomycin-resistance-encoding gene acts as a transcriptional silencer in eukaryotic cells. Gene 1991, 99:249-254.
7. Berkowitz R., Ilves H., Lin W.Y., Eckert K., Coward A., Tamaki S., Veres G., Plavec I. Construction and molecular analysis of gene transfer systems derived from bovine immunodeficiency virus. J. Virol. 2001, 75:3371-3382.
8. Bodine D.M., McDonagh K.T., Brandt S.J., Ney P.A., Agricola B., Byrne E., Niehuis A.W. Development of a high-titer retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 1990, 87:3738-3742.
9. Brinster R.L., Allen J.M., Behringer R.R., Gelinas R.E., Palmiter R.D. Introns increase transcriptional efficiency in transgenic mice. Proc. Natl. Acad. Sci. USA 1988, 85:836-840.
10. Burns J.C., Friedmann T., Driever W., Burrascano M., Yee J.-K. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 1993, 90:8033-8037.
11. Chan A.W.S., Homan E.J., Ballou L.U., Burns J.C., Bremel R.D. Transgenic cattle produced by reverse-transcribed gene transfer in oocytes. Proc. Natl. Acad. Sci. USA 1998, 95:14028-14033.
12. Chan A.W.S., Chong K.Y., Martinovich C., Simerly C., Schatten G. Transgenic monkeys produced by retroviral gene transfer into mature oocytes. Science 2001, 291:309-312.
13. Coffin J. Structure of retroviral genome. RNA Tumor Viruses 1982, 261-368. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. R. Weiss, N. Teich, H. Varmus, J. Coffin (Eds.).
14. Coffin J. Genome structure. RNA Tumor Viruses 1985, 17-73. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 2nd ed. R. Weiss, N. Teich, H. Varmus, J. Coffin (Eds.).
15. Coffin J.M. Retroviridae and their replication. Virology 1990, 1437-1500. Raven Press, New York. B.N. Fields, D.M. Knipe (Eds.).
16. Colicelli J., Goff S.P. Sequence and spacing requirements of retrovirus integration site. J. Mol. Biol. 1988, 199:47-59.
17. Danos O., Mulligan R.C. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA 1988, 85:6460-6464.
18. Deglon N., Tseng J.L., Bensadoun J.C., Zurn A.D., Arsenijevic Y., Pereira de Almeida L., Zufferey R., Trono D., Aebischer P. Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system for Parkinson's disease. Hum. Gene. Ther. 2000, 11:179-190.
19. + cells in the SCID-hu Thy/Liv model of human T cell lymphopoiesis. Hum. Gene Ther. 2001, 12:401-413.
20. Ellis J., Bernstein A. Retrovirus vectors containing an internal attachment site: evidence that circles are not intermediates to murine retrovirus integration. J. Virol. 1989, 63:2844-2846.
21. Emerman M., Temin H.M. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell (Cambridge, MA) 1984, 39:459-467.
22. Emerman M., Temin H.M. Quantitative analysis of gene suppression in integrated retrovirus vector. Mol. Cell. Biol. 1986, 6:792-800.
23. Fernex C., Dubreuil P., Mannoni P., Bagnis C. Cre/loxP-mediated excision of a neomycin resistance expression unit from an integrated retroviral vector increases long terminal repeat-driven transcription in human hematopoietic cells. J. Virol. 1997, 71:7533-7540.
24. Forestell S.P., Dando J.S., Chen J., de Vries P., Böhnlein E., Rigg R.J. Novel retroviral packaging cell lines: complementary tropisms and improved vector production for efficient gene transfer. Gene Ther. 1997, 4:600-610.
25. Harries M., Phillipps N., Anderson R., Prentice G., Collins M. Comparison of bicistronic vectors containing internal ribosome entry sites (IRES) using expression of human interleukin-12 (IL-12) as a readout. J. Gene Med. 2000, 2:243-249.
26. Hwang L.S., Gilboa E. Expression of genes introduced into cells by retroviral infection is more efficient than that of genes introduced into cells by DNA transfection. J. Virol. 1984, 50:417-424.
27. Hwang L.S., Park J., Gilboa E. Role of intron-contained sequences in formation of Moloney murine leukemia virus env mRNA. Mol. Cell. Biol. 1984, 4:2289-2297.
28. Iwasaki K., Temin H.M. The efficiency of RNA 3'-end formation is determined by the distance between the cap site and the poly(A) site in spleen necrosis virus. Genes Dev. 1990, 4:2299-2307.
29. Jaenisch R. Trangenic animals. Science 1988, 240:1468-1474.
30. Julius M.A., Yan Q., Zheng Z., Kitajewski J. Q vectors, bicistronic retroviral vectors for gene transfer. Biotechniques 2000, 28:702-708.
31. Kim T., Leibfried-Rutledge M.L., First N.L. Gene transfer into bovine cells and embryos using replication-defective retroviral vectors encapsidated with xenotropic murine leukemia virus envelopes. Anim. Biotechnol. 1993, 4:53-69.
32. Kozak S.L., Kabat D. Ping-pong amplication of a retroviral vector achieves high-level gene expression: human growth hormone production. J. Virol. 1990, 64:3500-3508.
33. Kurre P., Kiem H.P., Morris J., Heyward S., Battini J.L., Miller A.D. Efficient transduction by an amphotropic retrovirus vector is dependent on high-level expression of the cell surface virus receptor. J. Virol. 1999, 73:495-500.
34. Lindemann D., Patriquin E., Feng S., Mulligan R.C. Versatile retrovirus vector systems for regulated gene expression in vitro in vivo. Mol. Med. 1997, 3:466-476.
35. Linney E., Hardison N.L., Bonnie E.L., Lyons S., DiNapoli L. Transgene expression in zebrafish: a comparison of retroviral-vector and DNA-injection approaches. Dev. Biol. 1999, 213:207-216.
36. Lu J.K., Burns J.C., Chen T.T. Pantropic retroviral vector integration, expression, and germline transmission in medaka (Oryzias latipes). Mol. Mar. Biol. Biotechnol. 1997, 6:289-295.
37. Mann R., Baltimore D. Varying the position of a retrovirus packaging sequence results in the encapsidation of both unspliced and spliced RNAs. J. Virol. 1985, 54:401-407.
38. Mann R., Mulligan R.C., Baltimore D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell (Cambridge, MA) 1983, 33:153-159.
39. Markowitz D., Goff S., Bank A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology 1988, 167:400-406.
40. Markowitz D., Goff S., Bank A. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 1988, 62:1120-1124.
41. Miller A.D., Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 1986, 6:2895-2902.
42. Miller A.D., Rosman G.J. Improved retroviral vectors for gene transfer and expression. Biotechniques 1989, 7:980-990.
43. Miller A.D., Garcia J.V., von Suhr N., Lynch C.M., Wilson C., Eiden M.V. Construction and properties of retrovirus packaging cells based on Gibbon ape leukemia virus. J. Virol. 1991, 65:2220-2224.
44. Miyoshi H., Blomer U., Takahashi M., Gage F.H., Verma I.M. Development of self-inactivating lentivirus vector. J. Virol. 1998, 72:8150-8157.
45. Murdoch B., Pereira D.S., Wu X., Dick J.E., Ellis J. A rapid screening procedure for the identification of high titer retrovirus packaging clones. Gene Ther. 1997, 4:744-749.
46. Ory D.S., Neugeboren B.A., Mulligan R.C. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. USA 1996, 93:11400-11406.
47. Pacchia A.L., Adelson M.E., Kaul M., Ron Y., Dougherty J.P. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins. Virology 2001, 282:77-86.
48. Pear W.S., Nolan G.P., Scott M.L., Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 1993, 90:8392-8396.
49. Ponder K.P. Vectors of gene therapy. An Introduction to Molecular Medicine and Gene Therapy 2001, 77-112. Wiley-Liss, New York. T.F. Kresina (Ed.).
50. Reiser J., Harmison G., Kluepfel-Stahl S., Brady R.O., Karlsson S., Schubert M. Transduction of nondividing cells using pseudotyped defective high-titer HIV 1 particles. Proc. Natl. Acad. Sci. USA 1996, 93:15266-15271.
51. Rivière I., Sadelain M. Methods or the construction of retrovirus vectors and the generation of high-titer producers. Gene Therapy Protocol 1997, 59-78. Humana Press, Totowa, NJ. P.D. Robbins (Ed.).
52. Robbins P.B., Skelton D.C., Yu X.-J., Halene S., Leonard E.H., Kohn D.B. Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 1998, 95:10182-10187.
53. Rohdewohld H., Weiher H., Reik W., Jaenisch R., Breindl M. Retrovirus integration and chromatin structure: Moloney murine leukemia proviral integration sites map near DNase 1-hypersensitive sites. J. Virol. 1987, 61:336-343.
54. Saller R.M., Ozturk F., Salmons B., Gunzburg W.H. Construction and characterization of a hybrid mouse mammary tumor virus/murine leukemia virus-based retroviral vector. J. Virol. 1998, 72:1699-1703.
55. Savatier N., Rocancourt D., Bonnerot C., Nicolas J. A novel system for screening anti-retroviral agents. J. Virol. Methods 1989, 26:229-236.
56. Savatier P., Morgenstern J., Beddington R.S.P. Permissiveness to murine leukemia virus expression during preimplantation and early postimplantation mouse development. Development 1990, 109:655-665.
57. Sleckman B.P., Peterson A., Jones W.K., Foran J.A., Greenstein J.L., Seed B., Burakoff S.J. Expression and function of CD4 in a murine T-cell hybridoma. Nature 1987, 328:351-353.
58. Soriano P., Friedrich G., Lawinger P. Promoter interactions in retrovirus vectors introduced into fibroblasts and embryonic stem cells. J. Virol. 1991, 65:2314-2319.
59. Stevenson M., Stanwick T.L., Dempsey M.P., Lamonica C.A. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 1990, 9:1551-1560.
60. Takahara Y., Hamada K., Housman D.E. A new retrovirus packaging cell for gene transfer constructed from amplified long terminal repeat-free chimeric proviral genes. J. Virol. 1992, 66:3725-3732.
61. Teich N. Taxonomy of retroviruses. RNA Tumor Viruses 1982, 25-207. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. R. Weiss, N. Teich, H. Varmus, J. Coffin (Eds.).
62. Temin H.M. Retrovirus vectors for gene transfer: efficient integration into and expression of exogenous DNA in vertebrate cell genomes. Gene Transfer 1987, 149-187. Plenum Press, New York. R. Kuchelapati (Ed.).
63. Temin H.M. Mechanism of cell killing/cytopathic effects by nonhuman retroviruses. Rev. Infect. Dis. 1988, 10:399-405.
64. Temin H.M. Retrovirus variation and evolution. Genome 1989, 31:17-22.
65. Tong-Starksen S., Peterlin B.M. Mechanism of retroviral transcriptional activation. Semin. Virol. 1990, 1:215-227.
66. Weiss R. Experimental biology and assay of RNA tumor virus. RNA Tumor Viruses 1982, 209-260. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. R. Weiss, N. Teich, H. Varmus, J. Coffin (Eds.).
67. Whitcomb J.M., Hughes S.H. Retroviral reverse transcription and integration: progress and problems. Annu. Rev. Cell Biol. 1992, 8:275-306.
68. Yee J.-K., Friedmann T., Burns J.C. Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol. 1994, 43:99-112.
69. Zhao-Emonet J.C., Marodon G., Pioche-Durieu C., Cosset F.L., Klatzmann D. T cell-specific expression from Mo-MLV retroviral vector containing a CD4 mini-promoter/enhancer. J. Gene Med. 2000, 2:416-425.
70. Zhong Q., Kollis J.K., Schwarzenberger P. Retrovirus molecular conjugates: a novel, high transduction efficiency, potentially safety improved gene transfer system. J. Biol. Chem. 2001, 276:24601-24607.